Cliff Asness’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-492,751
Closed -$241K 2412
2023
Q2
$241K Sell
492,751
-1,495,790
-75% -$1.22M ﹤0.01% 2020
2023
Q1
$2.31M Buy
1,988,541
+1,431,113
+257% +$2.62M 0.01% 1196
2022
Q4
$1.49M Buy
557,428
+290,154
+109% +$765K ﹤0.01% 1383
2022
Q3
$764K Buy
267,274
+244,050
+1,051% +$1.04M ﹤0.01% 1614
2022
Q2
$115K Sell
23,224
-87,510
-79% -$458K ﹤0.01% 2076
2022
Q1
$787K Buy
+110,734
New +$916K ﹤0.01% 1647

Other funds holding CELL

Cliff Asness's CELL Position: Q3 2023 in Review

Cliff Asness sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2023, closing a stake of 492,751 shares — an estimated $241K sold.

Cliff Asness first reported a position in CELL in Q1 2022 and held it in 6 quarters. The position peaked at $2.31M in Q1 2023. 57 funds tracked by Wall St. Rank hold CELL as of Q3 2023.

  • Cliff Asness reported no remaining PhenomeX Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Cliff Asness sold 492,751 PhenomeX Inc. Common Stock shares in Q3 2023, an estimated $241K.
  • Cliff Asness first reported a position in PhenomeX Inc. Common Stock in Q1 2022 and held it in 6 quarters.
  • Cliff Asness's PhenomeX Inc. Common Stock position peaked at $2.31M in Q1 2023.
  • 57 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2023.

Based on AQR Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.